Top Stories
The neurotech startup has also undergone a restructuring that will see it shed jobs and scale back its operations in New York.
Patients with advanced NSCLC who underwent comprehensive genomic testing before first-line therapy were more likely to receive targeted treatments than those given narrower tests.
The French startup plans to expand its AI platform beyond colorectal and pancreatic cancers, using lab-grown patient tumours to predict how experimental drugs will perform in clinical trials.
The findings highlight the importance of looking beyond calcium and plaque to assess cardiovascular risk.
The Wellderly Brain Study is testing whether digital lifestyle coaching can influence Alzheimer's biomarkers, particularly p-tau217, as well as measures of cognitive and biological ageing.
Conference News
Envol scientists defined laboratory requirements and tested the system, which Resero Analytics developed for nonclinical labs. Envol is now validating it for its GLP studies.INDIANAPOLIS & OKEECHOBEE,...
Key takeaways: Few tools exist to identify patients at high risk of death after treatment for a ST‑elevation myocardial infarction, a type of heart attack. In the PERISCOPE project, machine-learning...
European Society of CardiologyEmbargo 13 November – 13:15 CET Key takeaways In the HerzMobil Steiermark programme, a mobile app and telemonitoring by specialists was implemented to support patients d...
A study modeling a 100,000-person workforce estimates that whole-body MRI could help detect most cancers and liver disease, and recover much of its cost through lower medical bills and fewer lost work...
Microchip-enabled sensing platform aims to combine signal acquisition, mapping and real-time catheter positioning to support future nerve-targeted proceduresTHE WOODLANDS, TX, Nov. 12, 2026 (GLOBE NEW...
